GALT Investors Have Opportunity to Join Galectin Therapeutics Inc. Fraud Investigation with The Schall Law Firm

Group 1 - GALT Investors have the opportunity to participate in a fraud investigation concerning Galectin Therapeutics Inc. [1] - The investigation is being conducted by The Schall Law Firm, which specializes in securities class action lawsuits. [1] - The focus of the investigation is to determine whether Galectin Therapeutics Inc. made false and misleading statements to investors. [1] Group 2 - The announcement highlights potential legal implications for Galectin Therapeutics Inc. and its management. [1] - Investors are encouraged to reach out to the law firm for more information regarding their rights and potential claims. [1] - The outcome of the investigation may impact the company's stock performance and investor sentiment. [1]